Tolemy Bio

Cambridge, United Kingdom

Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.

$1.6M raised

May 2026

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Tolemy Bio raised?

Tolemy Bio has raised $1.6M in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2026.

Who are Tolemy Bio's investors?

Tolemy Bio's investors include Marcel Hedman, David Ola, JME Ventures, Big Sur Ventures, Norrsken Evolve.

Where is Tolemy Bio headquartered?

Tolemy Bio is headquartered in Cambridge, United Kingdom.

What does Tolemy Bio do?

Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.

What stage is Tolemy Bio at?

Tolemy Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 12, 2026.

MLA

"Tolemy Bio — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/tolemy-bio. Accessed July 3, 2026.

APA

VCBacked. (2026). Tolemy Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tolemy-bio

Wikipedia (cite web)

{{cite web |title=Tolemy Bio — Funding & Investors |url=https://www.vcbacked.co/company/tolemy-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 12, 2026.